, Tarek Rashad Gharibeh3
, Mohammad Al-Hanaktah4
, Hussam Alshraideh5,6
, Raghad Mahmoud Darweesh7
, Maria Alshurman8, Lekaa Ja’far Al Mughrabi F9
, Yaqeen Ja’far Al Mughrabi F9
, Neveen Ghanem8 1Department of Family and Community Medicine, Faculty of Medicine, University of Jordan, Amman, Jordan
2Public Health Institute, University of Jordan, Amman, Jordan
3Department of Medicine, Faculty of Medicine, University of Jordan, Amman, Jordan
4Faculty of Medicine, University of Jordan, Amman, Jordan
5Department of Industrial Engineering, American University of Sharjah, Sharjah, UAE
6Industrial Engineering Department, Jordan University of Science and Technology, Irbid, Jordan
7Faculty of Medicine, Hashemite University, Zarqa, Jordan
8Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
9Faculty of Medicine, Mutah University, Al Karak, Jordan
Copyright © 2025 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Data Availability
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Conflict of Interest
The authors have no conflicts of interest associated with the material presented in this paper.
Funding
None.
Acknowledgements
We thank the management of Al-Bashir Hospital, Amman; Princess Rahma Hospital for Pediatrics, Irbid; Princess Basma Hospital, Irbid; Princess Badiea Hospital for Obstetrics and Gynecology, Irbid; Zarqa Governmental Hospital; Karak Governmental Hospital; Amman Comprehensive Healthcare Center and the comprehensive health centers in Zarqa, Karak, and Irbid for their great support.
Author Contributions
Conceptualization: Abu-Helalah M. Data curation: Darweesh RM, Alshurman M, Ja’far Al Mughrabi F L, Ja’far Al Mughrabi F Y, Ghanem N. Formal analysis: Alshraideh H, Al-Hanaktah M. Funding acquisition: None. Methodology: Abu-Helalah M. Project administration: Abu-Helalah M, Al-Hanaktah M. Visualization: Alshraideh H, Al-Hanaktah M. Writing – original draft: Abu-Helalah M, Gharibeh TR, Al-Hanaktah M. Writing – review & editing: Abu-Helalah M, Gharibeh TR, Al-Hanaktah M, Alshraideh H, Darweesh RM, Alshurman M, Ja’far Al Mughrabi F L, Ja’far Al Mughrabi F Y, Ghanem N.
| Characteristics | Vaccinated in the past year | p-value | |
|---|---|---|---|
| No (n=206) | Yes (n=183) | ||
| Age | 35.93±9.95 | 38.24±11.08 | 0.0131 |
| Sex | 0.7232 | ||
| Female | 74 (54.4) | 62 (45.6) | |
| Male | 132 (52.2) | 121 (47.8) | |
| Job experience (since ending internship) | 11.49±8.08 | 12.05±7.44 | 0.1011 |
| Designation | <0.0012 | ||
| Consultant | 31 (37.3) | 52 (62.7) | |
| General practitioner | 68 (66.7) | 34 (33.3) | |
| Specialist | 107 (52.5) | 97 (47.5) | |
| Specialty | 0.0752 | ||
| Obstetrician | 28 (63.6) | 16 (36.4) | |
| Pediatrics, family medicine, community medicine, and internal medicine | 116 (48.5) | 123 (51.5) | |
| Other specialties | 62 (58.5) | 44 (41.5) | |
| Practice location | 0.4142 | ||
| Clinic | 31 (60.8) | 20 (39.2) | |
| Clinic and hospital | 97 (53.0) | 86 (47.0) | |
| Hospital | 78 (50.3) | 77 (49.7) | |
| Governorate | 0.0202 | ||
| Middle | 133 (55.4) | 107 (44.6) | |
| North | 45 (42.4) | 61 (57.5) | |
| South | 28 (65.1) | 15 (34.9) | |
| How many times have you received the flu vaccine in your lifetime? | 2.09±2.41 | 5.60±4.75 | <0.0011 |
| Characteristics | Vaccinated in the past year | p-value | |
|---|---|---|---|
| No (n=206) | Yes (n=183) | ||
| Age | 35.93±9.95 | 38.24±11.08 | 0.013 |
| Sex | 0.723 | ||
| Female | 74 (54.4) | 62 (45.6) | |
| Male | 132 (52.2) | 121 (47.8) | |
| Job experience (since ending internship) | 11.49±8.08 | 12.05±7.44 | 0.101 |
| Designation | <0.001 | ||
| Consultant | 31 (37.3) | 52 (62.7) | |
| General practitioner | 68 (66.7) | 34 (33.3) | |
| Specialist | 107 (52.5) | 97 (47.5) | |
| Specialty | 0.075 | ||
| Obstetrician | 28 (63.6) | 16 (36.4) | |
| Pediatrics, family medicine, community medicine, and internal medicine | 116 (48.5) | 123 (51.5) | |
| Other specialties | 62 (58.5) | 44 (41.5) | |
| Practice location | 0.414 | ||
| Clinic | 31 (60.8) | 20 (39.2) | |
| Clinic and hospital | 97 (53.0) | 86 (47.0) | |
| Hospital | 78 (50.3) | 77 (49.7) | |
| Governorate | 0.020 | ||
| Middle | 133 (55.4) | 107 (44.6) | |
| North | 45 (42.4) | 61 (57.5) | |
| South | 28 (65.1) | 15 (34.9) | |
| How many times have you received the flu vaccine in your lifetime? | 2.09±2.41 | 5.60±4.75 | <0.001 |
| Items | Response | |
|---|---|---|
| Correct | Incorrect | |
| Influenza is more serious than a “common cold” | 358 (92.0) | 31 (8.0) |
| The signs and symptoms of influenza include fever, headache, sore throat, cough, nasal congestion, and aches and pains | 377 (96.9) | 12 (3.1) |
| Adults with influenza commonly experience nausea and vomiting | 143 (36.8) | 246 (63.2) |
| Adults with influenza commonly experience diarrhea | 140 (36.0) | 249 (63.9) |
| Influenza is transmitted primarily by coughing and sneezing | 381 (97.9) | 8 (2.1) |
| Influenza is transmitted primarily by contact with blood | 40 (10.3) | 349 (89.7) |
| Influenza is transmitted primarily by contact with body fluids | 162 (41.7) | 227 (58.3) |
| People with influenza can transmit the infection only after their symptoms appear | 101 (25.9) | 288 (74.1) |
| Not every HCP is familiar with influenza vaccination | 293 (75.4) | 96 (24.6) |
| HCPs are less susceptible to influenza infections than other people | 95 (24.4) | 294 (75.6) |
| HCPs can spread influenza even when they are feeling well | 352 (90.5) | 37 (9.5) |
| Symptoms typically appear 8–10 days after a person is exposed to influenza | 197 (50.8) | 192 (49.2) |
| Items | Response | |
|---|---|---|
| Yes | No | |
| Reason for influenza vaccination (n=389) | ||
| Vaccination will reduce the risk of getting influenza | 247 (63.5) | 142 (36.5) |
| Vaccination will reduce the severity of influenza | 1 (0.3) | 388 (99.7) |
| Vaccination will reduce the risk of transmitting influenza to high-risk patients | 183 (47.0) | 206 (53.0) |
| Reporting in scientific journals and in the media | 26 (6.7) | 363 (93.3) |
| Reduce symptoms | 1 (0.3) | 388 (99.7) |
| Job requirement | 1 (0.3) | 388 (99.7) |
| I belong to an influenza risk group | 131 (33.7) | 258 (66.3) |
| Reasons for not getting vaccinated against influenza (n=389) | ||
| Usually, my symptoms are mild | 6 (1.5) | 383 (98.5) |
| I question whether in my case vaccination will be effective | 45 (11.6) | 344 (88.4) |
| I forgot to get vaccinated | 121 (31.1) | 268 (68.9) |
| I fear side effects of the influenza vaccine | 64 (16.4) | 325 (83.5) |
| I prefer natural immunity | 0 (0) | 389 (100) |
| Due to reporting in scientific journals and in the media | 0 (0) | 389 (100) |
| I do not belong to an influenza risk group | 96 (24.7) | 293 (75.3) |
| I have good resistance to influenza | 6 (1.5) | 383 (98.5) |
| I am protected against influenza by frequent professional exposure to the virus | 77 (19.8) | 312 (80.2) |
| Characteristics | OR (95% CI) | p-value |
|---|---|---|
| Practice location | ||
| Clinic | 1.00 (reference) | |
| Clinic and hospital | 2.46 (1.01, 6.26) | 0.052 |
| Hospital | 2.53 (1.00, 6.65) | 0.053 |
| Governorate | ||
| Middle | 1.00 (reference) | |
| North | 2.06 (1.11, 3.89) | 0.023 |
| South | 0.81 (0.33, 1.91) | 0.602 |
| Perceived susceptibility: How many times have you got flu vaccine in your lifetime? | 1.60 (1.42, 1.82) | <0.001 |
| Perceived benefits: Do you think administering the influenza vaccine should be part of your routine medical practice? | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.15 (0.02, 0.63) | 0.019 |
| Neutral | 0.65 (0.29, 1.43) | 0.311 |
| Perceived benefits: It is better to go through an influenza infection than to get vaccinated against influenza | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.71 (0.33, 1.50) | 0.400 |
| Neutral | 1.57 (0.74, 3.38) | 0.222 |
| Perceived barriers: Side effects and safety concerns hinder physicians from vaccinating people against influenza | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 2.35 (1.14, 4.95) | 0.023 |
| Neutral | 0.54 (0.26, 1.09) | 0.089 |
| Perceived barriers: Side effects and safety concerns hinder HCPs from getting vaccinated for influenza | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.42 (0.19, 0.90) | 0.029 |
| Neutral | 0.51 (0.26, 0.97) | 0.041 |
| Perceived barriers: Not every HCP is familiar with influenza vaccination | ||
| Correct | 1.00 (reference) | |
| Incorrect | 1.82 (0.94, 3.56) | 0.078 |
| Not sure | 0.79 (0.33, 1.86) | 0.596 |
| Cues to action: I believe that flu vaccination for HCPs should be mandatory, unless contraindicated | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.18 (0.07, 0.43) | <0.001 |
| Neutral | 0.87 (0.41, 1.82) | 0.740 |
| Cues to action: Have you participated in any training/education related to the influenza vaccine in the past 12 mo? | ||
| No | 1.00 (reference) | |
| Not sure | 1.22 (0.29, 4.72) | 0.822 |
| Yes | 2.17 (1.05, 4.60) | 0.039 |
| Cues to action: There is insufficient staff to administer vaccines | ||
| All the time | 1.00 (reference) | |
| Little of the time | 3.03 (0.91, 10.80) | 0.078 |
| Most of the time | 4.83 (1.48, 17.10) | 0.011 |
| None of the time | 11.3 (3.61, 39.10) | <0.001 |
| Some of the time | 7.82 (2.63, 25.60) | <0.001 |
| Characteristics | OR (95% CI) | p-value |
|---|---|---|
| Vaccinated in the past year | ||
| No | 1.00 (reference) | |
| Yes | 2.17 (1.05, 4.60) | 0.039 |
| Sex | ||
| Female | 1.00 (reference) | |
| Male | 2.27 (1.01, 5.31) | 0.051 |
| Specialty | ||
| Obstetrician | 1.00 (reference) | |
| Other specialties | 0.26 (0.07, 0.92) | 0.039 |
| Pediatrics, family medicine, community medicine, and internal medicine | 1.25 (0.41, 3.79) | 0.731 |
| Practice from | ||
| Clinic | 1.00 (reference) | |
| Clinic and hospital | 0.21 (0.05, 0.78) | 0.024 |
| Hospital | 0.16 (0.04, 0.61) | 0.010 |
| Governorate | ||
| Middle | 1.00 (reference) | |
| North | 2.87 (1.16, 7.53) | 0.026 |
| South | 3.46 (0.98, 13.10) | 0.060 |
| Influenza is more serious than a “common cold” | ||
| Correct | 1.00 (reference) | |
| Incorrect | 0.16 (0.04, 0.59) | 0.007 |
| Not sure | 0.07 (0.01, 0.65) | 0.019 |
| Perceived susceptibility: HCPs are less susceptible to influenza infections than other people | ||
| Correct | 1.00 (reference) | |
| Incorrect | 2.89 (1.12, 7.84) | 0.032 |
| Not sure | 9.03 (1.99, 46.30) | 0.006 |
| Perceived severity: Influenza is not a serious condition; therefore, it is not worth vaccinating against | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.11 (0.03, 0.39) | <0.001 |
| Neutral | 0.67 (0.16, 2.77) | 0.610 |
| Perceived severity: The symptoms of influenza in healthy older adults (≥65 y of age) are so serious that this requires prevention by means of an effective vaccine. | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 18.60 (1.72, 243.00) | 0.019 |
| Neutral | 0.76 (0.25, 2.38) | 0.600 |
| Perceived severity: The possible complications of influenza could be serious enough to justify vaccination | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.32 (0.06, 1.45) | 0.140 |
| Neutral | 4.52 (1.21, 18.80) | 0.030 |
| Self-efficacy: I believe that the influenza vaccine is tolerable | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 1.43 (0.24, 8.38) | 0.733 |
| Neutral | 4.23 (1.43, 13.50) | 0.011 |
| Perceived barriers: Influenza vaccination does not work in some persons, even if the vaccine has the right mix of viruses | ||
| No | 1.00 (reference) | |
| Not sure | 0.18 (0.05, 0.59) | 0.007 |
| Yes | 0.19 (0.05, 0.59) | 0.006 |
| Perceived barriers: Side effects and safety concerns hinder physicians to get from vaccinating people vaccinated for against influenza | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.70 (0.25, 1.90) | 0.497 |
| Neutral | 2.60 (0.98, 7.23) | 0.060 |
| Perceived barriers: Cost-effectiveness has not been demonstrated sufficiently locally | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.27 (0.06, 1.08) | 0.068 |
| Neutral | 0.19 (0.06, 0.54) | 0.003 |
| Perceived susceptibility: Complications of influenza are that so rare that this does not justify vaccination | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 2.06 (0.67, 6.45) | 0.203 |
| Neutral | 5.37 (1.61, 19.60) | 0.008 |
| Perceived benefits: Do you agree with that the influenza vaccine will prevent complications of influenza particularly amongst patients at high risk such as those with chronic cardiac or respiratory illnesses | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.06 (0.00, 0.75) | 0.042 |
| Neutral | 0.16 (0.04, 0.59) | 0.007 |
| Perceived benefits : The effectiveness of the influenza vaccine regarding prevention of influenza has been proven sufficiently | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.01 (0.00, 0.06) | <0.001 |
| Neutral | 0.62 (0.18, 2.16) | 0.541 |
| Perceived benefits: The effectiveness of the influenza vaccine regarding prevention of complications and mortality has been proven sufficiently | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 2.19 (0.24, 22.60) | 0.530 |
| Neutral | 4.30 (1.21, 16.40) | 0.027 |
| Perceived benefits: The effectiveness regarding prevention of complications and mortality has not been proven sufficiently | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.12 (0.03, 0.46) | 0.003 |
| Neutral | 0.10 (0.03, 0.34) | <0.001 |
| Perceived benefits: The influenza vaccine prevents serious complications of an influenza infection among people above older than 65 y | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.02 (0.00, 0.22) | 0.003 |
| Neutral | 0.14 (0.02, 0.87) | 0.041 |
| Perceived benefits: The influenza vaccine prevents serious complications of an influenza infection among patients with chronic diseases | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 52.50 (1.95, 1,49) | 0.018 |
| Neutral | 0.96 (0.19, 5.09) | >0.999 |
| Cues to action: I believe I can play a key role in the vaccination of my patients | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.24 (0.03, 1.58) | 0.230 |
| Neutral | 0.11 (0.03, 0.34) | <0.001 |
| Cues to action: Have your staff participated in any training/education related to the influenza vaccine in the past 12 mo? | ||
| No | 1.00 (reference) | |
| Not applicable | 0.35 (0.07, 1.62) | 0.214 |
| Not sure | 1.00 (0.37, 2.65) | >0.999 |
| Yes | 3.62 (1.27, 11.00) | 0.018 |
| Self-efficacy: If you offer the influenza vaccines, what is the percentage of patients in your clinic/hospital who are provided with to whom you provide influenza vaccination in a month by you? (%) | ||
| 0–20 | 1.00 (reference) | |
| 21–40 | 2.46 (0.92, 6.86) | 0.078 |
| 41–60 | 4.58 (1.31, 17.40) | 0.020 |
| 61–80 | 1.47 (0.30, 7.34) | 0.610 |
| 81–100 | 167.00 (5.70, 8,89) | 0.006 |
| Self-efficacy: Which practice do you follow regarding influenza vaccine for your clinical unit? | ||
| None of the above | 1.00 (reference) | |
| We encourage and provide influenza vaccine | 427.00 (74.40, 3,39) | <0.001 |
| We encourage the influenza vaccine | 7.48 (2.85, 21.30) | <0.001 |
| We provide the influenza vaccine | 12.40 (3.42, 49.30) | <0.001 |
| Self-efficacy: How would you estimate the vaccination rate of your at-risk patients in the season 2021/2022? (%) | ||
| 0–20 | 1.00 (reference) | |
| 21–40 | 0.37 (0.13, 0.97) | 0.047 |
| 41–60 | 0.34 (0.11, 1.06) | 0.067 |
| 61–80 | 2.02 (0.47, 9.39) | 0.400 |
| 81–100 | 0.06 (0.00, 2.09) | 0.150 |
| Self-efficacy: Do you think administering the influenza vaccine should be part of your routine medical practice? | ||
| Agree/Strongly agree | 1.00 (reference) | |
| Disagree/Strongly disagree | 0.05 (0.01, 0.32) | 0.003 |
| Neutral | 0.20 (0.07, 0.53) | 0.002 |
Values are presented as mean±standard deviation or number (%). Wilcoxon rank sum test. Pearson’s chi-squared test.
Values are presented as number (%). HCP, healthcare professional.
Values are presented as number (%).
OR, odds ratio; CI, confidence interval; HCP, healthcare professional.
OR, odds ratio; CI, confidence interval; HCP, healthcare professional.